Gerardo Guillén is an expert in Infectiology at Latin American School of Medicine (Cuba). Gerardo Guillén has authored 235 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 634 (community average: 125). How the SLR is computed.

LeadR Profile

634 ScienceLeadR Reputation 634
Network Map

Infectiology

Subspecialties: Biochemistry - Immunology - Hepatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1998 - 2026

Source: PubMed

Centro de Ingeniería Genética y Biotecnología

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 235

Citations

Citations: 4 385 1st author: 4 Last author: 71 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Nucleos(t)ide Analog-Therapeutic Vaccination Switch: A Novel Approach for Safe and Effective Treatment Discontinuation in HBeAg (-) Chronic Hepatitis B Patients.
PMID 42797641 — safety, vaccines, hepatitis, chronic, vaccination, hepatitis b e antigens, therapeutics, hepatitis b, antiviral agents, hepatitis b, chronic, hepatitis
Vaccines (Basel)20260
EGF and GHRP6 Co-Administration Attenuates Cognitive Decline in Preclinical Models: Behavioral and Molecular Evidences.
PMID 42399524 — genes, growth, neuronal plasticity, cognitive dysfunction, aged, therapeutics
Neurotox Res20260
A discovery-based proteomic approach of epidermal growth factor and growth hormone-releasing peptide-6 in a model of acute ischemic stroke.
PMID 42258095 — epidermal growth factor, growth, ischemic stroke, stroke, brain, hormones, pharmacology, therapeutics, growth hormone
Pharmacol Rep20260
Growth Hormone-Releasing Peptide-6 (GHRP-6) Ameliorates Post-Infarct Ventricular Remodeling and Systolic Dysfunction in a Model of Permanent Coronary Ligation.
PMID 41901314 — ventricular remodeling, growth, hormones, ligation, growth hormone
Pharmaceuticals (Basel)20260
The Sustainable Goal of Eliminating Hepatitis B, Functional Cure, and the Prospect of NASVAC: A Review.
PMID 41757140 — viruses, therapeutics, hepatitis b, hepatitis
Euroasian J Hepatogastroenterol20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Unknown 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map